Hyperbaric Oxygen Therapy for Acute Domestic Carbon Monoxide (CO) Poisoning

NCT ID: NCT01100515

Last Updated: 2010-04-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

PHASE3

Total Enrollment

179 participants

Study Classification

INTERVENTIONAL

Study Start Date

1989-10-31

Study Completion Date

2000-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Carbon monoxide poisoning still places a burden on the healthcare system worldwide. While oxygen therapy is the cornerstone treatment, the role and practical modalities of hyperbaric oxygen therapy (HBO) remain controversial. This study aimed at comparing one session of HBO at 2 absolute atmosphere followed by 4 hours of normobaric oxygen therapy to 6 hours of normobaric oxygen therapy in adult victims of acute domestic carbon monoxide poisoning and without coma.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Carbon Monoxide Poisoning

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental arm

Hyperbaric oxygen therapy at 2 absolute atmosphere (1-hour plateau) followed by 4 hours of normobaric oxygen therapy

Group Type EXPERIMENTAL

Hyperbaric oxygen therapy

Intervention Type OTHER

Hyperbaric oxygen therapy was delivered in a hyperbaric chamber, pressurized at 2 absolute atmosphere (1 hour plateau) and the patient breathed high oxygen concentration via a full face mask followed by 4 hours of normobaric oxygen therapy

Control

6 hours course of normobaric oxygen therapy via a face full mask

Group Type ACTIVE_COMPARATOR

normobaric oxygen therapy

Intervention Type OTHER

oxygen therapy was delivered via a full face mask at high flow to achieve 100% of inspired oxygen fraction

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

normobaric oxygen therapy

oxygen therapy was delivered via a full face mask at high flow to achieve 100% of inspired oxygen fraction

Intervention Type OTHER

Hyperbaric oxygen therapy

Hyperbaric oxygen therapy was delivered in a hyperbaric chamber, pressurized at 2 absolute atmosphere (1 hour plateau) and the patient breathed high oxygen concentration via a full face mask followed by 4 hours of normobaric oxygen therapy

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients older than 15 years of age
* admitted for domestic CO poisoning within 12 hours after the end of CO exposure.
* had transient loss of consciousness (syncope, malaise)
* carboxyhemoglobin level at presentation \>10% or 5%, in smokers and non-smokers, respectively.

Exclusion Criteria

* poisoning by more than one compound (e.g., CO plus a drug or CO plus other toxic gases such as those found in fire smoke
* suicide attempt
* pregnancy
* coma
* contraindications to HBO (circulatory collapse or pneumothorax)
* technical obstacles to HBO
* non domestic CO poisoning
* difficulty in determining whether the patient experienced initial loss of consciousness or initial coma
* consent refusal.
Minimum Eligible Age

15 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assistance Publique - Hôpitaux de Paris

OTHER

Sponsor Role collaborator

University of Versailles

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

DRRC Assistance Publique Hôpitaux de Paris

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Raymond Poincaré Hospital

Garches, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CO89

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Drowning-related Acute Respiratory Failure
NCT06183827 NOT_YET_RECRUITING NA
Hyperbaric Oxygen in Lower Leg Trauma
NCT00264511 COMPLETED PHASE2/PHASE3